TFRC and systemic lupus erythematosus: Blockage of transferrin receptor led to reduction of intracellular iron and mTORC1 signalling, which in turn inhibited TH1 and TH17 cells but enhanced Treg differentiation and was associated with amelioration of disease severity in lupus-prone mice.